Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Surfactants”

175 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 175 results

Large-scale testing (Phase 3)Ended earlyNCT02772081
What this trial is testing

A Study in Preterm Neonates With Respiratory Distress Syndrome (RDS) Comparing CUROSURF® Administration Through Less Invasive Surfactant Administration (LISA) and Conventional Administration

Who this might be right for
Respiratory Distress Syndrome (RDS)
Chiesi Farmaceutici S.p.A. 33
Not applicableStudy completedNCT00771992
What this trial is testing

Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma

Who this might be right for
Asthma
Fraunhofer-Institute of Toxicology and Experimental Medicine 15
Not applicableLooking for participantsNCT07251725
What this trial is testing

GEN-FPF: Genetic Exploration of Familial Pulmonary Fibrosis

Who this might be right for
Familial Pulmonary Fibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia 126
Post-approval studies (Phase 4)UnknownNCT05364385
What this trial is testing

Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease

Who this might be right for
Infant, Extremely PrematureAcute Lung InjuryChronic Lung Disease of Prematurity+1 more
University of Arizona 25
Not applicableAvailableNCT06546098
What this trial is testing

Molgramostim Nebulizer Solution Expanded Access Program Protocol

Who this might be right for
Autoimmune Pulmonary Alveolar Proteinosis
Savara Inc.
Testing effectiveness (Phase 2)UnknownNCT04019106
What this trial is testing

Budesonide With Intratracheal Surfactants in Extremely Preterm Infants

Who this might be right for
Bronchopulmonary DysplasiaRespiratory Distress Syndrome in Premature Infant
University of Manitoba 30
Testing effectiveness (Phase 2)Ended earlyNCT04264156
What this trial is testing

A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age

Who this might be right for
Respiratory Distress Syndrome, Newborn
Windtree Therapeutics 12
Not applicableStudy completedNCT04811274
What this trial is testing

Macrophages, GM-CSF and MARS Proteinosis

Who this might be right for
Pulmonary Alveolar Proteinosis (PAP)MARSGenetic Mutation
Assistance Publique - Hôpitaux de Paris 20
Large-scale testing (Phase 3)Study completedNCT00000570
What this trial is testing

Human Surfactant Treatment of Respiratory Distress Syndrome Bicenter Trial

Who this might be right for
Lung DiseasesRespiratory Distress Syndrome
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableStudy completedNCT05024435
What this trial is testing

Evaluation of Semi-rigid and Flexible Catheters for Less Invasive Surfactant Administration in Preterm Infants

Who this might be right for
NeonatologyPerinatal Distress Syndrome
Salzburger Landeskliniken 31
Not applicableLooking for participantsNCT05002478
What this trial is testing

Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial

Who this might be right for
Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Surfactant DysfunctionInfant
Medical University of Vienna 14
Testing effectiveness (Phase 2)Study completedNCT02452476
What this trial is testing

A Double Blind, Randomized, Controlled Study to Evaluate CHF 5633 (Synthetic Surfactant) and Poractant Alfa in Neonates With Respiratory Distress Syndrome (RDS) (POC)

Who this might be right for
Respiratory Distress Syndrome, Newborn
Chiesi Farmaceutici S.p.A. 123
Testing effectiveness (Phase 2)UnknownNCT04825197
What this trial is testing

Late Surfactant After a Recruitment Maneuver in Extremely Low Gestational Age Newborns - LATE-REC-SURF Trial

Who this might be right for
Bronchopulmonary DysplasiaChronic Pulmonary Insufficiency of Prematurity
VENTO GIOVANNI 20
Testing effectiveness (Phase 2)Ended earlyNCT01615016
What this trial is testing

MISurf Versus InSurE. A Comparison of Minimally Invasive Surfactant Application Techniques in Preterm Infants

Who this might be right for
Hyaline Membrane Disease
Hamilton Health Sciences Corporation 4
Post-approval studies (Phase 4)Looking for participantsNCT06007547
What this trial is testing

Prophylactic Minimally Invasive Surfactant Evaluation

Who this might be right for
Respiratory Distress Syndrome, NewbornPremature Birth
Endeavor Health 200
Early research (Phase 1)Ended earlyNCT03748173
What this trial is testing

Infasurf®(Calfactant) Aerosol for Infants With Bronchiolitis-AERO-04

Who this might be right for
Bronchiolitis
ONY 13
Large-scale testing (Phase 3)Study completedNCT00563641
What this trial is testing

Very Early Surfactant and NCPAP for Premature Infants With RDS

Who this might be right for
Respiratory Distress SyndromePneumothorax/Pulmonary Intersticial EmphysemaChronic Lung Disease
Colombian Neonatal Research Network 278
Large-scale testing (Phase 3)Ended earlyNCT01306240
What this trial is testing

Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation

Who this might be right for
Acute Respiratory Distress Syndrome
Centre Hospitalier Universitaire, Amiens 19
Large-scale testing (Phase 3)Study completedNCT03058666
What this trial is testing

Comparison of Aerosol Delivery of Infasurf to Usual Care in Spontaneously Breathing RDS Patients

Who this might be right for
Respiratory Distress Syndrome
ONY 477
Large-scale testing (Phase 3)UnknownNCT02774044
What this trial is testing

Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates

Who this might be right for
Respiratory Distress Syndrome
Ramesh K Agarwal 900
Next Page